Literature DB >> 9539951

Hormone action and chromatin remodelling.

D Robyr1, P Wolffe.   

Abstract

Current attention in transcriptional regulation is focused on the properties of coactivators and corepressors that mediate communication between sequence-specific transcription factors, the basal transcriptional machinery and the chromatin environment. Nuclear and steroid hormone receptors represent the best-understood transcription factors that utilize coactivators and corepressors. This review considers the access of these receptors to chromatin, the modifications of chromatin structure that the receptors instigate and the implications for transcriptional control. Nucleosome positioning and targeted histone modification emerge as central controlling elements for gene expression.

Mesh:

Substances:

Year:  1998        PMID: 9539951     DOI: 10.1007/s000180050130

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  5 in total

Review 1.  Selective estrogen receptor modulators: a look ahead.

Authors:  B H Mitlak; F J Cohen
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 2.  Chromatin architecture defines the glucocorticoid response.

Authors:  Craig J Burd; Trevor K Archer
Journal:  Mol Cell Endocrinol       Date:  2013-03-29       Impact factor: 4.102

3.  Chromatin context dominates estrogen regulation of pS2 gene expression.

Authors:  Akua K Oduro; Michael K Fritsch; Fern E Murdoch
Journal:  Exp Cell Res       Date:  2008-07-15       Impact factor: 3.905

4.  Epigenome-Microbiome crosstalk: A potential new paradigm influencing neonatal susceptibility to disease.

Authors:  Rene Cortese; Lei Lu; Yueyue Yu; Douglas Ruden; Erika C Claud
Journal:  Epigenetics       Date:  2016-02-24       Impact factor: 4.861

5.  Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells.

Authors:  M Barshishat; S Polak-Charcon; B Schwartz
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.